findmyKOL

John Tesser, MD

Enriched profile

Rheumatologist, MD, FACP, FACR, MACR · Arizona Arthritis & Rheumatology Associates

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Phoenix, AZ · West · United StatesSpecialtyRheumatologyFocusRheumatoid Arthritis
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

John Tesser is Rheumatologist, MD, FACP, FACR, MACR at Arizona Arthritis & Rheumatology Associates. OpenAlex indexes 61 publications with 4,901 citations (h-index 24); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

John R. P. Tesser, MD, is Rheumatologist, MD, FACP, FACR, MACR at Arizona Arthritis & Rheumatology Associates, P.C.. The public record shows 61 publications with 4,901 citations (h-index 24), centered on Rheumatoid Arthritis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 41 companies.

  • Most recent indexed publication: 2025 · BioDrugs
  • Top research focus: Rheumatoid Arthritis
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 41 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Rheumatoid Arthritis1 trial

Research focus

OpenAlex concept fingerprint
Rheumatoid Arthritis

Drugs & molecules

across trials, industry payments and publications
Rinvoqgeneric · UpadacitinibClinical trials—Industry payments210Publications1Tremfyageneric · GuselkumabClinical trials—Industry payments184Publications3Xeljanzgeneric · TofacitinibClinical trials—Industry payments70Publications1Inflectrageneric · InfliximabClinical trials—Industry payments40Publications1Humirageneric · AdalimumabClinical trials—Industry payments31Publications2Simponigeneric · GolimumabClinical trials—Industry payments7Publications2SIMPONI ARIAClinical trials—Industry payments148Publications—Taltzgeneric · IxekizumabClinical trials—Industry payments105Publications—Benlystageneric · BelimumabClinical trials—Industry payments90Publications—Enbrelgeneric · EtanerceptClinical trials—Industry payments82Publications—Saphnelogeneric · AnifrolumabClinical trials—Industry payments78Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments63Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments273Janssen Biotech, Inc.Clinical trials—Industry payments154Amgen Inc.Clinical trials—Industry payments152Lilly USA, LLCClinical trials—Industry payments140UCB, Inc.Clinical trials—Industry payments102AstraZeneca Pharmaceuticals LPClinical trials—Industry payments98GlaxoSmithKline, LLC.Clinical trials—Industry payments90Pfizer Inc.Clinical trials—Industry payments79Janssen Scientific Affairs, LLCClinical trials—Industry payments55Novartis Pharmaceuticals CorporationClinical trials—Industry payments40Genzyme CorporationClinical trials—Industry payments29E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments28Aurinia Pharma U.S., Inc.Clinical trials—Industry payments25Radius Health, Inc.Clinical trials—Industry payments16Genentech USA, Inc.Clinical trials—Industry payments15Horizon Therapeutics plcClinical trials—Industry payments13Fresenius Kabi USA, LLCClinical trials—Industry payments11Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments8Averitas Pharma Inc.Clinical trials—Industry payments7Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments6Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments5Janssen Global Services, LLCClinical trials—Industry payments5Kyowa Kirin, Inc.Clinical trials—Industry payments3Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments2ANI Pharmaceuticals, Inc.Clinical trials—Industry payments2Biogen, Inc.Clinical trials—Industry payments2Celltrion USA Inc.Clinical trials—Industry payments2Exeltis, USA Inc.Clinical trials—Industry payments2Ferring Pharmaceuticals Inc.Clinical trials—Industry payments2Organon LLCClinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
61publications

Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.

4,901citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
41companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    71.3%
    TNF inhibitor31.2%
    Certolizumab pegol65%Golimumab28%Infliximab7%Enbrel Sureclick0%Humira(Cf) Pen0%Humira(Cf)0%Enbrel0%Simponi0%
    Part D + Part B<11 patients
    Interleukin-6 Receptor Antagonist28.7%
    Tocilizumab100%Kevzara0%
    Part D + Part B<11 patients

    + 6 more classes in this area

  • Musculoskeletal

    28.1%
    Other drugs affecting bone structure and mineralization19.1%
    Romosozumab-aqqg100%
    Part B, office-administered≥44 patients
    RANK Ligand Inhibitor8.9%
    Denosumab100%
    Part B, office-administered≥227 patients

    + 8 more classes in this area

  • Metabolism & gastrointestinal

    0.2%
    Corticosteroid0.1%
    Prednisone100%
    Part D≥122 patients
    Aminosalicylate0%
    Sulfasalazine100%
    Part D≥24 patients

    + 3 more classes in this area

All 10 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/john-tesser-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    rheumnow.com/user/20981

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/John-Tesser-2138282770

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/Rheumatology/videos/dr-john-tesser-explains-the-theory-of-how-vagus-nerve-stimulation-could-be-effec/1319878595989423

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
  • LinkedIn

    linkedin.com/posts/american-college-of-rheumatology_dr-john-tesser-explains-the-theory-of-how-activity-7303084038074912769-T1mx

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/ACRheum/status/1897377844088725881

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • B.S.

    Yale University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • M.D.

    University of Rochester School of Medicine and Dentistry

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Residency in Internal Medicine

    Maricopa Medical Center, Phoenix, AZ

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
  • Fellowship in Rheumatology

    Bowman Gray School of Medicine, Winston-Salem, NC

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Board Certified

    Internal Medicine and Rheumatology, American Board of Internal Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Rheumatology (FACR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Fellow

    American College of Physicians (FACP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Member

    American Society of Bone and Mineral Research

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →azarthritis.com ↗
  • Member

    International Society of Clinical Densitometry

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →azarthritis.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Clinical Lecturer

    University of Arizona Health Sciences Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Adjunct Assistant Professor of Medicine

    Division of Clinical Education, Midwestern University, Arizona College of Osteopathic Medicine, Phoenix, AZ

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →azarthritis.com ↗
  • Principal Investigator

    Arizona Arthritis & Rheumatology Research PLLC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eventscribe.net ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.